Harvard Law School launches first-of-its-kind psychedelics research initiative
In a significant stride towards a more comprehensive understanding of psychedelics, the Petrie-Flom Center for Health Law Policy, Biotechnology, and…
Morgan Stanley’s Counterpoint Global eyes potential of psychedelics
Morgan Stanley's Counterpoint Global team, a collective of investors and researchers, has turned its focus to the potential of psychedelics.…
FDA releases guidance for psychedelic drug development
In an unprecedented move, the U.S. Food and Drug Administration (FDA) has released guidance for researchers developing novel medicines, a…
Kentucky invests $42 million in Ibogaine research
In a groundbreaking move, the state of Kentucky has decided to invest a whopping $42 million in research on a…
Senate Committee on Appropriations directs medical marijuana Access for vets
The Senate Committee on Appropriations has recently issued directives that could potentially revolutionize the medical industry. These directives focus on…
Pennsylvania Senator John Fetterman advocates for psilocybin mushrooms
Pennsylvania Senator Governor John Fetterman recently spoke out in support of psilocybin mushrooms as a potential mental health treatment and…
Psilocybin therapy found to be effective treatment for alcohol addiction
A new study has revealed that psilocybin therapy can be an effective treatment for alcohol addiction. The study, which is…
Harvard Law School launches research initiative on psychedelics and the law
Harvard Law School's Petrie-Flom Center has launched a new research initiative focused on the intersection of psychedelics and the law.…
US House passes bill to criminalize fentanyl-related substances
The United States House of Representatives has passed a bill that would criminalize fentanyl-related substances, but it also includes provisions…
Morgan Stanley report highlights potential of psychedelic drugs in mental health treatment
Morgan Stanley, one of the world's leading investment banks, has published a report on the potential of psychedelic drugs in…
